When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Astellas Pharma to buy Audentes Therapeutics for $60/share
Astellas Pharma Inc
Audentes Therapeutics (NASDAQ:BOLD) agrees to be acquired by Astellas Pharma (OTCPK:ALPMF) for US$60/share in cash, representing a total equity value of ~US$3B; shares are halted.
More news on: Audentes Therapeutics, Inc., Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news, Merger & acquisition news,